No connection

Search Results

HDSN

BEARISH
$6.0 Live
Hudson Technologies, Inc. · NASDAQ
Target $9.0 (+50.0%)
$5.14 52W Range $10.52

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 11, 2026
Market cap
$258.02M
P/E
16.22
ROE
6.8%
Profit margin
6.8%
Debt/Equity
0.02
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
HDSN exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic YoY EPS decline of 116.7%. While the company maintains a clean balance sheet with very low debt (D/E 0.02) and trades below its Graham Number ($6.98), the divergence between strong revenue growth (28.2%) and negative operating margins (-16.23%) suggests an unsustainable operational model. Insider selling and a bearish technical trend further undermine the optimistic analyst target of $9.00.

Key Strengths

Very low leverage with a Debt/Equity ratio of 0.02
Strong short-term liquidity with a Current Ratio of 3.26
Robust top-line revenue growth of 28.20% YoY
Trading at a reasonable Price-to-Book ratio of 1.03
Current price is below the defensive Graham Number ($6.98)

Key Risks

Severe operational inefficiency indicated by a -16.23% operating margin
Critical decline in profitability with YoY EPS growth at -116.7%
Weak financial health baseline (Piotroski F-Score 2/9)
Strong insider selling pressure totaling $7.18M
Negative technical momentum with a 31.8% decline over the last 6 months
AI Fair Value Estimate
Based on comprehensive analysis
$4.75
-20.8% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
30
Weak
Value
55
Future
30
Past
45
Health
20
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score deterioration, EPS collapse, Operating margin deficit, Insider divestment
Confidence
90%
Value
55/100

P/E of 16.22 is moderate, but Graham Number suggests a ceiling near $6.98.

Positives
  • P/B near 1.0
  • Price below Graham Number
Watchpoints
  • Price significantly above growth-based intrinsic value ($2.59)
Future
30/100

Revenue growth is not translating to bottom-line profitability.

Positives
  • Strong revenue growth (28%)
Watchpoints
  • Earnings growth is deeply negative
  • Operating margins are failing to scale with revenue
Past
45/100

Long-term gains are being erased by recent operational failures.

Positives
  • Strong 5-year historical return (+195.6%)
Watchpoints
  • Recent 6-month trend is sharply bearish (-31.8%)
Health
20/100

Balance sheet is solvent, but operational health is in distress.

Positives
  • Negligible debt
  • High current ratio
Watchpoints
  • Piotroski F-Score of 2/9 indicates weak financial health
Dividend
0/100

Non-dividend paying stock.

Positives
No standout positives identified.
Watchpoints
  • No dividend payments
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$6.0
Analyst Target
$9.0
Upside/Downside
+50.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for HDSN and closest competitors.

Updated 2026-04-10
HDS
Hudson Technologies, Inc.
Primary
5Y
+195.6%
3Y
-27.7%
1Y
+8.5%
6M
-31.8%
1M
+1.2%
1W
+2.7%
ARE
American Resources Corporation
Peer
5Y
-41.2%
3Y
+71.4%
1Y
+330.2%
6M
-18.0%
1M
-30.1%
1W
-12.0%
ALT
Alto Ingredients, Inc.
Peer
5Y
-18.0%
3Y
+142.7%
1Y
+253.0%
6M
+294.9%
1M
+68.2%
1W
+6.2%
AMT
Aemetis, Inc.
Peer
5Y
-88.1%
3Y
-17.0%
1Y
+44.0%
6M
+6.0%
1M
+50.7%
1W
+63.6%
FRD
Friedman Industries, Incorporated
Peer
5Y
+127.7%
3Y
+62.8%
1Y
+27.1%
6M
-13.4%
1M
+2.4%
1W
+4.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
16.22
Forward P/E
13.33
PEG Ratio
N/A
P/B Ratio
1.03
P/S Ratio
1.05
EV/Revenue
0.9
EV/EBITDA
7.73
Market Cap
$258.02M

Profitability

Profit margins and return metrics

Profit Margin 6.76%
Operating Margin -16.23%
Gross Margin 25.18%
ROE 6.81%
ROA 4.54%

Growth

Revenue and earnings growth rates

Revenue Growth +28.2%
Earnings Growth N/A
Q/Q Revenue Growth +28.19%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.02
Low debt
Current Ratio
3.26
Strong
Quick Ratio
0.97
Poor
Cash/Share
$0.93

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
8.0%
Op. Margin
-25.2%
Net Margin
-19.4%
Total Assets
$0.3B
Liabilities
$0.1B
Equity
$0.2B
Debt/Equity
0.31x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
103%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-06
$N/A
2026-03-04
$-0.13
-52.9% surprise
2025-11-05
$0.27
+40.3% surprise
2025-07-30
$0.23
+53.3% surprise

Basic Materials Sector Comparison

Comparing HDSN against 60 companies in the Basic Materials sector (1 bullish, 27 neutral, 32 bearish)
P/E Ratio
16.22
This Stock
vs
47.21
Sector Avg
-65.7% (Discount)
Return on Equity (ROE)
6.81%
This Stock
vs
-5.96%
Sector Avg
-214.3% (Below Avg)
Profit Margin
6.76%
This Stock
vs
-8.72%
Sector Avg
-177.5% (Weaker)
Debt to Equity
0.02
This Stock
vs
0.52
Sector Avg
-95.8% (Less Debt)
Revenue Growth
28.2%
This Stock
vs
37.17%
Sector Avg
-24.1% (Slower)
Current Ratio
3.26
This Stock
vs
3.96
Sector Avg
-17.5% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

HOUGHTON KATHLEEN
Officer and Director
Option Exercise
2026-01-08
218,507 shares · $360,074
COLEMAN BRIAN F
Director
Sell
2025-12-05
484,616 shares · $3,588,097
COLEMAN BRIAN F
Former
Sell
2025-12-05
484,616 shares · $3,588,097
ABBATECOLA VINCENT P
Director
Buy
2025-11-17
3,500 shares · $23,748
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
4 analysts
Canaccord Genuity
2026-03-06
Maintains
Buy Buy
Roth Capital
2026-03-06
Maintains
Neutral Neutral
B. Riley Securities
2026-03-05
Maintains
Buy Buy
Canaccord Genuity
2025-11-10
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning HDSN from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile